Oxolamine citrate salt
CAS: 1949-20-8
Ref. 3D-BAA94920
2g | 136,00 € | ||
5g | 172,00 € | ||
10g | 248,00 € | ||
25g | 363,00 € | ||
50g | 518,00 € |
Informação sobre produto
- 1,2,4-Oxadiazole, 5-[2-(diethylamino)ethyl]-3-phenyl-, citrate (1:1)
- 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- 3-Phenyl-5-(diethylaminoethyl)-1,2,4-oxadiazole citrate
- 5-(Diethylaminoethyl)-3-phenyl-1,2,4-oxadiazole citrate
- 5-[2-(Diethylamino)Ethyl]-3-Phenyl-1,2,4-Oxadiazole Citrate Salt
- Af 438
- Bredon
- Broncatar
- Flogobron
- N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanaminium 3,4-dicarboxy-3-hydroxybutanoate
- Ver mais sinónimos
- NSC 100298
- Oxarmin
- Oxolamine Dihydrogen Citrate
- Perebron
- Prilon
- Skf 9976
Oxolamine citrate salt is a pharmaceutical drug used for the treatment of scleroderma. It acts as an iron chelator and inhibits the production of the cytotoxic agent, podophyllotoxin, by inhibiting its conversion to epipodophyllotoxin. Oxolamine citrate salt has been shown to have a beneficial effect on Alzheimer's disease and may have therapeutic potential in other neurological diseases such as Parkinson's disease. The compound has been shown to inhibit acetonitrile-induced hyperactivity in mice. Oxolamine citrate salt has also been found to be effective against Pseudomonas aeruginosa and Staphylococcus aureus isolates that are resistant to oxacillin, ginkgetin, or pseudoephedrine. This drug can be analyzed using liquid chromatography with an acetonitrile gradient and a hypersil C18 column.
Propriedades químicas
Consulta técnica sobre: 3D-BAA94920 Oxolamine citrate salt
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.